Qingyan Au

Qingyan (Sandy) Au currently serves as the Senior Director of Multiplexing at NeoGenomics Laboratories since December 2015, overseeing the scientific and operational functions of the Multiplex Immunofluorescence modality. This includes management of platforms such as MultiOmyx™ and PhenoImager/Vectra Polaris™, as well as imaging analysis for both IHC and multiplexed IF/IHC assays. Prior to this role, Qingyan held various positions at GE Healthcare from April 2013 to December 2015 and worked at the Sanford Burnham Medical Research Institute between November 2009 and April 2013. Qingyan began a career in research at CytRx Corporation from 2007 to 2009. Educational qualifications include a Ph.D. in Biomedical Sciences from the University of California, Riverside and a Master’s degree in Genetics from Fudan University.